CN106110244A - 咳喘散 - Google Patents
咳喘散 Download PDFInfo
- Publication number
- CN106110244A CN106110244A CN201610522895.4A CN201610522895A CN106110244A CN 106110244 A CN106110244 A CN 106110244A CN 201610522895 A CN201610522895 A CN 201610522895A CN 106110244 A CN106110244 A CN 106110244A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- asthma
- cough
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010011224 Cough Diseases 0.000 title claims abstract description 77
- 208000006673 asthma Diseases 0.000 title claims abstract description 53
- 239000000843 powder Substances 0.000 title claims abstract description 30
- 210000000582 semen Anatomy 0.000 claims abstract description 31
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 235000012907 honey Nutrition 0.000 claims description 16
- 230000000694 effects Effects 0.000 abstract description 35
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 19
- 208000024891 symptom Diseases 0.000 abstract description 15
- 206010006451 bronchitis Diseases 0.000 abstract description 10
- 206010014561 Emphysema Diseases 0.000 abstract description 9
- 208000030603 inherited susceptibility to asthma Diseases 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 4
- 238000006243 chemical reaction Methods 0.000 abstract description 3
- 229940126678 chinese medicines Drugs 0.000 abstract description 2
- 210000004072 lung Anatomy 0.000 description 23
- 238000011282 treatment Methods 0.000 description 19
- 206010062717 Increased upper airway secretion Diseases 0.000 description 13
- 239000003814 drug Substances 0.000 description 13
- 208000026435 phlegm Diseases 0.000 description 13
- 201000010099 disease Diseases 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 11
- 206010036790 Productive cough Diseases 0.000 description 7
- 239000003172 expectorant agent Substances 0.000 description 6
- 230000003419 expectorant effect Effects 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 208000013116 chronic cough Diseases 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 210000001113 umbilicus Anatomy 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010006458 Bronchitis chronic Diseases 0.000 description 2
- 206010011703 Cyanosis Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000037656 Respiratory Sounds Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 206010047924 Wheezing Diseases 0.000 description 2
- 230000000954 anitussive effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 229940124584 antitussives Drugs 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 208000007451 chronic bronchitis Diseases 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 206010052613 Allergic bronchitis Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003497 Asphyxia Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010009866 Cold sweat Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010017999 Gastrointestinal pain Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 206010021079 Hypopnoea Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 210000001142 back Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 201000005737 orchitis Diseases 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 235000020610 powder formula Nutrition 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000008203 tachypnea Diseases 0.000 description 1
- 206010043089 tachypnoea Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940070384 ventolin Drugs 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002912 waste gas Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及中药技术领域,具体公开了一种咳喘散,由以下重量份的原料组成:桔梗15‑30份、荆芥15‑30份、紫苑15‑30份、前胡15‑30份、百部15‑30份、黄芩15‑30份、五味子15‑30份、杏仁15‑30份、桃仁15‑30份、知母15‑20份、川贝母15‑20份、牙皂30‑50份、干姜8‑12份、冰片1‑5份。本发明对于支气管炎、支气管哮喘、肺气肿等咳喘病症有很好的疗效,还能够增强人体自身的免疫力和抵抗力,能够有效控制病情不复发,无明显毒副作用和不良反应,具有较好的社会和经济效益。
Description
技术领域
本发明涉及中药技术领域,具体涉及一种咳喘散。
背景技术
咳喘是当今世界上难以根治的病症之一,是呼吸系统的多发病,可由感冒、支气管炎等病引发,无论男女老幼,一年四季均可发病,患者众多,尤以年老体弱者在季节或天气变换时易发,患病时常有咽喉部瘙痒、不适、气粗痰多、呼吸不畅等症状。此病具有对人体健康危害大、发病率高、病程长等特点,给病人带来了极大的痛苦和麻烦。
目前,在临床上治疗此类病症的药物虽多,但疗效不尽如人意。西医对咳嗽、喘息等症状采用可待因等镇咳药物和氯化铵等祛痰药物对症治疗,虽可做到暂时控制症状,但必需合并使用抗生素等抗菌药物以达到治愈目的。而抗生素的滥用会造成较严重的后果,如破坏人体免疫力,治愈时间长且不能根治,有些慢性支气管炎引发的咳嗽也不宜长期使用抗生素治疗。经典中医理论认为,咳喘的发生,为宿痰内伏于肺,复加外感、饮食、体虚病后等因素,以致痰堵气道、废气上逆所致。虽然中医中药对咳喘的病理病机有着较深入的认识,在其治疗方面有着较明显的优势,但目前还没有发现在疗效和市场上都较具优势的中医药物。
发明内容
针对现有技术的不足,本发明提供了一种咳喘散,对支气管炎、支气管哮喘、肺气肿等咳喘病有显著疗效,无毒副作用,治愈率高且不复发。
为实现以上目的,本发明通过以下技术方案予以实现:
一种咳喘散,由以下重量份的原料组成:桔梗15-30份、荆芥15-30份、紫苑15-30份、前胡15-30份、百部15-30份、黄芩15-30份、五味子15-30份、杏仁15-30份、桃仁15-30份、知母15-20份、川贝母15-20份、牙皂30-50份、干姜8-12份、冰片1-5份。
优选地,由以下重量份的原料组成:桔梗25-30份、荆芥25-30份、紫苑20-25份、前胡20-25份、百部15-20份、黄芩25-30份、五味子18-23份、杏仁15-20份、桃仁20-25份、知母15-18份、川贝母15-18份、牙皂35-45份、干姜8-12份、冰片1-5份。
优选地,由以下重量份的原料组成:桔梗25份、荆芥27份、紫苑22份、前胡24份、百部18份、黄芩26份、五味子20份、杏仁17份、桃仁23份、知母16份、川贝母17份、牙皂44份、干姜10份、冰片3份。
优选地,所述紫苑为蜜炙紫苑。
优选地,所述百部为蜜炙百部。
本发明中各原料药物的功效如下:
桔梗:性平,味苦、辛,归肺经,具有宣肺祛痰、利咽排脓的功效,用于治疗咳嗽痰多、胸膈满闷、咽痛音哑、肺疽吐脓。
荆芥:性微温,味辛,归肺经、肝经,具有发表散风、透疹的功效,用治感冒、头痛、麻疹、风疹、疮疡初起,有抑菌、解热、解痉、促进汗腺分泌、消炎和止血作用。
紫苑:性温,味辛、苦,归肺经,具有润肺下气、消痰止咳的功效,用治痰多喘咳、新久咳嗽、劳嗽咳血。现代药理试验证实,紫苑有祛痰镇咳作用,并对金黄色葡萄球菌、痢疾杆菌、伤寒杆菌、大肠杆菌、绿脓杆菌、霍乱弧菌皆有抑制作用,对结核杆菌亦有抑制作用。
前胡:性微寒,味苦、辛,归肺经,具有发表镇痛、降气化痰的功效,用治外感表证、头痛昏眩、痰热喘满、咯痰黄稠、风热咳嗽痰多。
百部:性微温,味甘、苦,归肺经,具有润肺止咳,杀虫灭虱的功效,主治外感咳嗽,常配荆芥、桔梗、紫菀等。
黄芩:性寒,味苦,归肺经、胆经、脾经、大肠经、小肠经,具有清热燥湿、泻火解毒、止血、安胎的功效。黄芩具有较广的抗菌谱,对杆菌、球菌有抑制作用,对流感病毒、皮肤真菌亦有作用,临床上用于治疗湿温、暑温胸闷呕恶、湿热痞满、泻痢、黄疸、肺热咳嗽、高热烦渴、血热吐衄、痈肿疮毒、胎动不安。
五味子:性温,味酸、甘,归肺经、心经、肾经,具有收敛固涩、益气生津、补肾宁心的功效,可用于治疗久嗽虚喘。
杏仁:性微温,味苦,有小毒,归肺、大肠经,具有止咳平喘、润肠通便的功效,用于咳嗽气喘、肠燥便秘等症。
桃仁:性平,味苦、甘,归心经、肝经、大肠经,具有活血祛痰、润肠通便的功效。现代药理试验证实,桃仁有有抗凝血、改善血流、抗炎和抗过敏等作用,并能止咳、平喘,对肺结核有一定疗效。
知母:性寒,味苦、甘,归肺经、胃经、肾经,具有清热泻火、生津润燥的功效,用治外感热病、高热烦渴、肺热燥咳、骨蒸潮热、内热消渴、肠燥便秘。
川贝母:性微寒,味苦、甘,归肺经、心经,具有清热润肺、化痰止咳的功效,用治虚劳咳嗽、吐痰咯血、心胸郁结、肺痈、瘿瘤、瘰疬、喉痹。
牙皂:性温,味辛、咸,有小毒,归肺、大肠经,具有通关利窍、敷肿痛消、祛痰的功效,用于寒湿壅滞、胸闷喘咳、痰多而咯吐不爽者。
干姜:性热,味辛。归脾经、胃经、心经、肾经、肺经,具有温中散寒、回阳通脉、燥湿消痰的功效,用治脘腹冷痛、肢冷脉微、痰饮喘咳、胃肠气痛和绞痛、风湿痛、腰腿痛、胃及十二指肠溃疡、急性菌痢、急性睾丸炎、蛔虫病肠梗阻、慢性消化不良。
冰片:性寒,味辛、苦。归心经、脾经、肺经,具有开窍醒神、清热止痛的功效。
本发明有益效果:本发明依据传统中医中药机理及多年临床试验研究,所得咳喘散配方中诸药相辅相成,共奏清热宣肺、补益脾肾、化痰散结、止咳平喘之功效,从根本上治疗咳喘,对于支气管炎、肺气肿、支气管哮喘等咳喘病症有很好的疗效,且不易复发,无明显毒副作用和不良反应,还能够提高人体免疫力,肚脐给药使用方便,有较好的社会和经济效益。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚,下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1:
一种咳喘散,由以下重量份的原料组成:桔梗25份、荆芥27份、紫苑22份、前胡24份、百部18份、黄芩26份、五味子20份、杏仁17份、桃仁23份、知母16份、川贝母17份、牙皂44份、干姜10份、冰片3份。
咳喘散制备方法:按比例称取桔梗、荆芥、紫苑、前胡、百部、黄芩、五味子、杏仁、桃仁、知母、川贝母、牙皂、干姜,粉碎,过100目筛,向其中加入医用凡士林,按照常规膏剂制备方法制备即可。
实施例2:
一种咳喘散,由以下重量份的原料组成:桔梗28份、荆芥26份、蜜炙紫苑24份、前胡22份、蜜炙百部17份、黄芩28份、五味子21份、杏仁16份、桃仁22份、知母17份、川贝母16份、牙皂38份、干姜9份、冰片4份。
咳喘散的制备方法同实施例1。
实施例3:
一种咳喘散,由以下重量份的原料组成:桔梗25份、荆芥30份、蜜炙紫苑20份、前胡25份、蜜炙百部15份、黄芩30份、五味子18份、杏仁20份、桃仁20份、知母18份、川贝母15份、牙皂45份、干姜8份、冰片5份。
咳喘散的制备方法同实施例1。
实施例4:
一种咳喘散,由以下重量份的原料组成:桔梗30份、荆芥25份、蜜炙紫苑25份、前胡20份、蜜炙百部20份、黄芩25份、五味子23份、杏仁15份、桃仁25份、知母15份、川贝母18份、牙皂35份、干姜12份、冰片1份。
咳喘散的制备方法同实施例1。
实施例5:
一种咳喘散,由以下重量份的原料组成:桔梗15份、荆芥30份、蜜炙紫苑15份、前胡30份、蜜炙百部15份、黄芩30份、五味子15份、杏仁30份、桃仁15份、知母20份、川贝母15份、牙皂50份、干姜8份、冰片5份。
咳喘散的制备方法同实施例1。
实施例6:
一种咳喘散,由以下重量份的原料组成:桔梗30份、荆芥15份、蜜炙紫苑30份、前胡15份、蜜炙百部30份、黄芩15份、五味子30份、杏仁15份、桃仁30份、知母15份、川贝母20份、牙皂30份、干姜12份、冰片1份。
咳喘散的制备方法同实施例1。
实施例7:
一种咳喘散,由以下重量份的原料组成:桔梗22份、荆芥25份、蜜炙紫苑18份、前胡21份、蜜炙百部16份、黄芩15-30份、五味子25份、杏仁17份、桃仁18份、知母17份、川贝母16份、牙皂40份、干姜8份、冰片3份。
咳喘散的制备方法同实施例1。
临床案例:
经过药效的检测以及临床病例发现,实施例1中的药物药效最佳。
病例选择:选择240例咳喘病患者,其中患支气管哮喘80例、支气管炎80例,肺气肿80例,其中男性有106例,女性有134例,年龄在30-70岁之间,哮喘临床表现为:胸闷、喘息、气促、哮鸣音、喉痒干咳、呼吸困难、咳嗽、咳痰、痰白有气泡不易咳出、并在后半夜发作居多、严重时可口唇青紫、全身冷汗、焦虑不安、心悸多汗、严重烦躁、面脚浮肿、不能平卧、心跳紊乱、血压下降、甚至窒息死亡。支气管炎临床表现为:咳嗽、咳痰,以晨起最为显着,发作时有哮鸣音,喘憋严重,呼吸费力,不能平卧。肺气肿临床表现为:呼吸困难和紫绀,主要表现为进行性气急,起初在劳动或上楼时气急,后来在一般活动或平地行走,甚至说话、穿衣乃至休息也有气急,病情严重时,因缺氧,口唇及指端出现青紫,肺气肿后期可发展为肺心病。将上述240例咳喘病患者随机分成治疗组和对照组,支气管哮喘治疗组和对照组各40人,支气管炎治疗组和对照组各40人,肺气肿治疗组和对照组各40人。所有病例均属发作期,两组患者病例病种、病程、性别、年龄、临床症状等资料经统计学处理无显著差异(P>0.05)具有可比性。
治疗方法:对以上咳喘病患者进行治疗,治疗组采用本发明实施例1制备的咳喘散,肚脐给药,每日一贴;对照组常规服用黄龙咳喘胶囊,一次4粒,一日3次,且对于咯脓性痰者给予抗感染及祛痰治疗。
疗效判断标准:治愈:主、次症状全部消失;显效:主、次症状具有明显改善;有效:主、次症状均有所改善;无效:主、次症状未见改善。
治疗结果:7天为一疗程,治疗周期为4个疗程,治疗结果见下表:
表1治疗组和对照组的咳喘病症治疗效果
从表中可以看出,治疗组的治愈率和总有效率明显高于对照组,说明本发明的咳喘散对于支气管炎、支气管哮喘、肺气肿等咳喘病有很好的疗效,且肚脐给药,使用方便。
典型病例
病例1:张某,女,65岁,患病30年,早先确诊为慢性支气管炎,后发展为肺气肿、肺心病。临床3年,每日靠输液、口服止喘药维持,浑身乏力,病情日益加重,不得根治。采用本发明实施例1制备的咳喘散治疗3疗程后,病症显著改善,可自行上下楼,继续治疗3疗程后,症状完全消失,随访1年,未复发。
病例2:李某,男,45岁,咳嗽长达一月有余,以干咳为主,夜间尤为严重,服用镇咳药和抗生素后症状均得到有效缓解,但一经停药后复发。采用本发明实施例2制备的咳喘散1疗程后,白日基本上不咳嗽,夜间咳嗽症状有所减轻,睡眠质量大为改善,继续治疗1疗程后,症状彻底消失,继续膏贴1疗程巩固,随访一年未复发。
病例3:姜某,女,30岁,确诊为过敏性支气管炎、肺部感染,阵发哮喘,咽喉干痒,服用西药和常规中药治疗效果不佳,采用本发明实施例3制备的咳喘散治疗3疗程后,症状全部消失,随访一年未复发。
综上所述,通过临床验证,本发明的咳喘散对于支气管炎、支气管哮喘、肺气肿等咳喘病症有很好的疗效,并且能够有效控制病情不复发。此外,本发明的咳喘散还能够增强人体自身的免疫力和抵抗力。
以上实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的精神和范围。
Claims (5)
1.一种咳喘散,其特征在于,由以下重量份的原料组成:桔梗15-30份、荆芥15-30份、紫苑15-30份、前胡15-30份、百部15-30份、黄芩15-30份、五味子15-30份、杏仁15-30份、桃仁15-30份、知母15-20份、川贝母15-20份、牙皂30-50份、干姜8-12份、冰片1-5份。
2.如权利要求1所述的咳喘散,其特征在于,由以下重量份的原料组成:桔梗25-30份、荆芥25-30份、紫苑20-25份、前胡20-25份、百部15-20份、黄芩25-30份、五味子18-23份、杏仁15-20份、桃仁20-25份、知母15-18份、川贝母15-18份、牙皂35-45份、干姜8-12份、冰片1-5份。
3.如权利要求2所述的咳喘散,其特征在于,由以下重量份的原料组成:桔梗25份、荆芥27份、紫苑22份、前胡24份、百部18份、黄芩26份、五味子20份、杏仁17份、桃仁23份、知母16份、川贝母17份、牙皂44份、干姜10份、冰片3份。
4.如权利要求3所述的咳喘散,其特征在于,所述紫苑为蜜炙紫苑。
5.如权利要求3所述的咳喘散,其特征在于,所述百部为蜜炙百部。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610522895.4A CN106110244A (zh) | 2016-07-04 | 2016-07-04 | 咳喘散 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610522895.4A CN106110244A (zh) | 2016-07-04 | 2016-07-04 | 咳喘散 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106110244A true CN106110244A (zh) | 2016-11-16 |
Family
ID=57469426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610522895.4A Pending CN106110244A (zh) | 2016-07-04 | 2016-07-04 | 咳喘散 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106110244A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111671867A (zh) * | 2020-05-11 | 2020-09-18 | 首都医科大学附属北京中医医院 | 用于治疗冠状病毒肺炎咳嗽的中药组合物 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101036745A (zh) * | 2007-04-05 | 2007-09-19 | 马学荣 | 治疗儿童咳嗽、支气管炎的中药药贴 |
| CN105125984A (zh) * | 2015-08-21 | 2015-12-09 | 郑州市儿童医院 | 一种治疗小儿咳嗽的水性外用中药贴 |
-
2016
- 2016-07-04 CN CN201610522895.4A patent/CN106110244A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101036745A (zh) * | 2007-04-05 | 2007-09-19 | 马学荣 | 治疗儿童咳嗽、支气管炎的中药药贴 |
| CN105125984A (zh) * | 2015-08-21 | 2015-12-09 | 郑州市儿童医院 | 一种治疗小儿咳嗽的水性外用中药贴 |
Non-Patent Citations (1)
| Title |
|---|
| 樊茂蓉: ""天杏咳喘贴治疗慢性支气管炎急性发作的临床研究"", 《北京中医药》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111671867A (zh) * | 2020-05-11 | 2020-09-18 | 首都医科大学附属北京中医医院 | 用于治疗冠状病毒肺炎咳嗽的中药组合物 |
| CN111671867B (zh) * | 2020-05-11 | 2021-09-07 | 首都医科大学附属北京中医医院 | 用于治疗轻症的新型冠状病毒肺炎咳嗽的中药组合物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103920106A (zh) | 一种治疗慢性支气管炎和支气管哮喘的中药组合物 | |
| CN103536889B (zh) | 一种治疗老年慢性气管炎合并肺气肿的中药汤剂 | |
| CN101549101B (zh) | 一种用于治疗尘肺病和耐药性肺结核病的中药及制备方法 | |
| CN103191269A (zh) | 一种治疗慢性支气管炎的中药汤剂 | |
| CN105412749A (zh) | 一种治疗小儿肺炎喘嗽的药物及其制备和使用方法 | |
| CN103169885A (zh) | 一种治疗小儿哮喘的中药组合物 | |
| CN101085269B (zh) | 一种内服治疗肺癌的中药组合物 | |
| CN104922346A (zh) | 一种治疗慢性咽炎的中药 | |
| CN103933439A (zh) | 一种治疗慢性支气管炎的中药 | |
| CN104623148A (zh) | 治疗咳喘的药物及其口服液的制备方法 | |
| CN106110244A (zh) | 咳喘散 | |
| CN102526236A (zh) | 一种治疗流行性感冒的药物及其制备方法 | |
| CN105998809A (zh) | 一种治疗慢性咽炎的中药组合物 | |
| CN105748899A (zh) | 一种治疗咽炎的药物制剂及其用途 | |
| CN104173737A (zh) | 一种治疗肺间质纤维化的中药配方 | |
| CN104107344A (zh) | 一种治疗慢性支气管炎的中药组合物 | |
| CN104147334A (zh) | 一种祛痰药的中药配方 | |
| CN104606533A (zh) | 一种治疗咽炎的中药汤剂 | |
| CN103285229B (zh) | 一种治疗心脏病的茶 | |
| CN101985020B (zh) | 一种治疗气管炎的中药 | |
| CN101181509B (zh) | 一种内服治疗肺气肿的中药配方 | |
| CN101181500B (zh) | 一种用于治疗呼吸系统疾病的外用药物及其制备方法 | |
| CN104258231A (zh) | 一种治疗咳嗽的中药组合物 | |
| CN104958653A (zh) | 一种治疗结核病的中药组合物 | |
| CN101829286B (zh) | 润肺止咳丸 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161116 |
|
| RJ01 | Rejection of invention patent application after publication |